NOVO.B.DK

241.65

-3.13%↓

GMAB.DK

1,682.5

-2.04%↓

HLUNB.DK

37.86

+0.42%↑

ZEAL.DK

279.7

-6.05%↓

AMBUB.DK

69.95

-1.13%↓

NOVO.B.DK

241.65

-3.13%↓

GMAB.DK

1,682.5

-2.04%↓

HLUNB.DK

37.86

+0.42%↑

ZEAL.DK

279.7

-6.05%↓

AMBUB.DK

69.95

-1.13%↓

NOVO.B.DK

241.65

-3.13%↓

GMAB.DK

1,682.5

-2.04%↓

HLUNB.DK

37.86

+0.42%↑

ZEAL.DK

279.7

-6.05%↓

AMBUB.DK

69.95

-1.13%↓

NOVO.B.DK

241.65

-3.13%↓

GMAB.DK

1,682.5

-2.04%↓

HLUNB.DK

37.86

+0.42%↑

ZEAL.DK

279.7

-6.05%↓

AMBUB.DK

69.95

-1.13%↓

NOVO.B.DK

241.65

-3.13%↓

GMAB.DK

1,682.5

-2.04%↓

HLUNB.DK

37.86

+0.42%↑

ZEAL.DK

279.7

-6.05%↓

AMBUB.DK

69.95

-1.13%↓

Search

Coloplast A-S (Class B)

Fechado

446.4 -2.62

Visão Geral

Variação de preço das ações

24h

Atual

Mín

441.9

Máximo

460.2

Indicadores-chave

By Trading Economics

Rendimento

522M

1.4B

Vendas

83M

7B

P/E

Médio do Setor

25.56

57.833

EPS

6.32

Rendimento de Dividendos

5.07

Margem de lucro

19.835

Funcionários

16,983

EBITDA

309M

2.3B

Recomendações

By TipRanks

Recomendações

Neutro

Previsão para 12 meses

+11.86% upside

Dividendos

By Dow Jones

Rendimento de Dividendos

Médio do Setor

5.07%

2.47%

Próximos Ganhos

12 de mai. de 2026

Próxima data de dividendos

20 de mai. de 2026

Próxima data de ex-dividendo

18 de mai. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-17B

102B

Abertura anterior

449.02

Fecho anterior

446.4

Coloplast A-S (Class B) Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

18 de mar. de 2026, 22:51 UTC

Ganhos

AIA Group Value of New Business Rose in 2025, Plans $1.7 Billion New Share Buyback

18 de mar. de 2026, 21:40 UTC

Aquisições, Fusões, Aquisições de Empresas

Constellation Energy to Sell Portfolio of Assets for $5 Billion to Satisfy Regulators

18 de mar. de 2026, 20:31 UTC

Ganhos

Micron 2Q Sales Nearly Triple Amid Tight Memory Supply

18 de mar. de 2026, 23:49 UTC

Conversa de Mercado
Notícias Principais

Nikkei May Fall on Renewed Concerns About Higher Energy Prices -- Market Talk

18 de mar. de 2026, 23:31 UTC

Conversa de Mercado

Gold Rises on Likely Technical Recovery -- Market Talk

18 de mar. de 2026, 22:49 UTC

Conversa de Mercado

New Zealand's Economic Recovery Has Yet to Find Footing -- Market Talk

18 de mar. de 2026, 22:41 UTC

Conversa de Mercado

Woodside Energy Opts for 'Safe, Experienced' Choice as CEO -- Market Talk

18 de mar. de 2026, 22:36 UTC

Ganhos

AIA Group Value of New Business Rose in 2025, Plans $1.7B New Share Buyback

18 de mar. de 2026, 22:24 UTC

Ganhos

AIA Group Announces New Share Buyback of $1.7B >1299.HK

18 de mar. de 2026, 22:23 UTC

Ganhos

AIA Group 2025 Value of New Business Margin Was 58.5%, Up 3.6 Ppt on Year >1299.HK

18 de mar. de 2026, 22:23 UTC

Ganhos

AIA Group 2025 Value of New Business $5.52B Vs. $4.71B >1299.HK

18 de mar. de 2026, 21:58 UTC

Ganhos

Micron Sales Nearly Triple Amid Tight Memory Supply -- Update

18 de mar. de 2026, 21:55 UTC

Conversa de Mercado
Ganhos

Global Equities Roundup: Market Talk

18 de mar. de 2026, 21:55 UTC

Conversa de Mercado
Ganhos

Micron's Phone, PC Business Could Shrink Due to Memory Shortage -- Market Talk

18 de mar. de 2026, 21:40 UTC

Conversa de Mercado

Fuel Price Rise Equates to 20 Bps Rate Hike on Australian Households -- Market Talk

18 de mar. de 2026, 21:16 UTC

Conversa de Mercado

More Procter & Gamble Alumni Join Strobel at Coty -- Market Talk

18 de mar. de 2026, 21:00 UTC

Notícias Principais

Iran War Puts Pressure on Japan's Economy. Takaichi Is In a Bind. -- Barrons.com

18 de mar. de 2026, 20:58 UTC

Ganhos

Micron 2Q Gross Margin Nearly Doubled Due to Higher Pricing, CFO Says

18 de mar. de 2026, 20:41 UTC

Ganhos

Micron Reports Extraordinary Earnings. Its Growth Is Accelerating. -- Barrons.com

18 de mar. de 2026, 20:29 UTC

Ganhos

Micron Reports Extraordinary Earnings. Its Growth Is Accelerating. -- Barrons.com

18 de mar. de 2026, 20:25 UTC

Ganhos

Micron Reports Extraordinary Earnings. Its Growth Is Accelerating. -- Barrons.com

18 de mar. de 2026, 20:17 UTC

Ganhos

These Stocks Are Today's Movers: Micron, Swarmer, Lumentum, Trade Desk, Macy's, Williams-Sonoma, and More -- Barrons.com

18 de mar. de 2026, 20:14 UTC

Conversa de Mercado

Airlines Can't Offset Higher Fuel Prices for Long -- Market Talk

18 de mar. de 2026, 20:09 UTC

Ganhos

Micron Reports Extraordinary Earnings. The Stock Is Up. -- Barrons.com

18 de mar. de 2026, 20:07 UTC

Ganhos

Micron Technology Raises Qtr Dividend to 15c Vs. 11.5c >MU

18 de mar. de 2026, 20:06 UTC

Ganhos

Micron Technology Board Has Approved 30% Increase in Qtrly Div >MU

18 de mar. de 2026, 20:04 UTC

Ganhos

Micron Technology 2Q Operating Cash Flow $11.9 B >MU

18 de mar. de 2026, 20:04 UTC

Ganhos

Micron Technology Sees 3Q Operating Expenses About $1.6 B >MU

18 de mar. de 2026, 20:04 UTC

Ganhos

Micron Technology Sees 3Q Gross Margin About 81% >MU

18 de mar. de 2026, 20:03 UTC

Ganhos

Micron Technology Sees 3Q Adj EPS $19.15 +/- 40c >MU

Comparação entre Pares

Variação de preço

Coloplast A-S (Class B) Previsão

Preço-alvo

By TipRanks

11.86% parte superior

Previsão para 12 meses

Média 901.38 DKK  11.86%

Máximo 1,056 DKK

Mínimo 720 DKK

Com base em 8 analistas de Wall Street que oferecem metas de preço de 12 meses para Coloplast A-S (Class B) - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Neutro

8 ratings

2

Comprar

4

Manter

2

Vender

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Coloplast A-S (Class B)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.
help-icon Live chat